Avenue Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ATXI

Based on 1 analyst offering 12 month price targets for Avenue Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell ATXI stock?

Based on 1 analyst offering ratings for Avenue Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATXI stock forecasts and price targets.

ATXI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Aegis Capital
Bottom 23%
Strong BuyInitiates Coverage On$32.00+2,782.88%2023-04-03

1 of 1

ATXI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATXI$1.11$32.00+2,782.88%Strong Buy

Avenue Therapeutics Stock Forecast FAQ

Is Avenue Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ATXI) stock is to Strong Buy ATXI stock.

Out of 1 analyst, 1 (100%) are recommending ATXI as a Strong Buy, 0 (0%) are recommending ATXI as a Buy, 0 (0%) are recommending ATXI as a Hold, 0 (0%) are recommending ATXI as a Sell, and 0 (0%) are recommending ATXI as a Strong Sell.

If you're new to stock investing, here's how to buy Avenue Therapeutics stock.

What is ATXI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ATXI price target, the average ATXI price target is $32.00, with the highest ATXI stock price forecast at $32.00 and the lowest ATXI stock price forecast at $32.00.

The Wall Street analyst predicted that Avenue Therapeutics's share price could reach $32.00 by Apr 3, 2024. The average Avenue Therapeutics stock price prediction forecasts a potential upside of 2,782.88% from the current ATXI share price of $1.11.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.